More support for testing CTC as a diagnostic tool in formulating treatment plans for mCSPC patients. From the MedPageToday interview article:
"Baseline circulating tumor cell (CTC) count was found to be significantly predictive of clinical outcome in a phase III trial of metastatic castration-sensitive prostate cancer (mCSPC) presented at the 2020 American Society of Clinical Oncology virtual scientific meeting."
"In this exclusive MedPage Today video, lead researcher Amir Goldkorn, MD, of the Keck School of Medicine and Norris Comprehensive Cancer Center at the University of Southern California, explains that the results suggest that CTC count could be used as a noninvasive biomarker to help guide treatment decisions."
Nal, FYI i've just finished labs for both my cancers. Look for a private message over the weekend re: Neem Leaf.
As for rainy weather here in the state where we share opposite ends, at least the last two days I've been able see some small patches of blue sky. This past week has been pretty much non-stop overcast>drizzle>showers>rain 24/7. Forecast looks to be more of the same for the next two weeks! With the temps over the last several months trending consistently 5- 10 degrees below normal and wind blowing 10+ mph for 5 out of seven days each week, this amounts to Very, VERY strange weather so far this year. More so than any of the 15 years I've been a liveaboard. Seems the sunspot activity is sheltering-at-home and we are suffering the consequences?
Full sun today - Hope you're getting similar and able to get the zero-gravity chair out to capture some wide-spectrum rays. Remember to try and stay somewhat grounded, 'tho. Paz, Captain Sunshine
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.
